Mortality Reduction Associated With β-Adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With Diabetes.

Witte, KK orcid.org/0000-0002-7146-7105, Drozd, M orcid.org/0000-0003-0255-4624, Walker, AMN et al. (9 more authors) (2018) Mortality Reduction Associated With β-Adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With Diabetes. Diabetes Care, 41 (1). pp. 136-142. ISSN 0149-5992

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 by the American Diabetes Association. This is an author-created, uncopyedited electronic version of an article accepted for publication in Diabetes Care. The American Diabetes Association (ADA), publisher of Diabetes Care, is not responsible for any errors or omissions in this version of the manuscript or any version derived from it by third parties. The definitive publisher-authenticated version will be available in a future issue of Diabetes Care in print and online at : https://doi.org/10.2337/dc17-1406
Dates:
  • Published: January 2018
  • Accepted: 10 September 2017
  • Published (online): 5 October 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM)
Depositing User: Symplectic Publications
Date Deposited: 10 Oct 2017 14:23
Last Modified: 23 Mar 2018 13:32
Status: Published
Publisher: American Diabetes Association
Identification Number: https://doi.org/10.2337/dc17-1406
Related URLs:

Share / Export

Statistics